Go Back

The Stigma Around Ozempic for Weight Loss

category: Weight Loss

In our society, body weight is a complex and sensitive topic that often comes with significant judgment. In this blog post, we will explore the use of Semaglutide, brand name Ozempic or Wegovy as weight loss treatments.

Understanding Ozempic

Ozempic also known as Semaglutide is a medication used primarily to treat type 2 diabetes. However, in recent years, these drugs have shown promise in helping people with obesity achieve significant weight loss. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by reducing appetite, limiting cravings, and increasing feelings of fullness, leading to reduced food intake. These medications also increase insulin sensitivity, aiding in better glucose metabolism and diabetes prevention. Other GLP-1 agonists you may hear of are Mounjuro (Tirzepatide) and Wegovy (Semaglutide).

Despite their compelling benefits and safety profile, the use of these medications for weight loss is often met with various stigmas.

The Impact of Obesity and Access to Treatment

The impact obesity has on morbidity, mortality, and the financial burden is profound. While the pivotal role of diet, lifestyle, and exercise in averting and addressing obesity is undeniable, the scope of intervention extends beyond these factors. Individuals struggling with conditions such as hypertension, diabetes, pre-diabetes, or other metabolic issues require proactive guidance toward increased physical activity, smoking cessation, and moderation in alcohol consumption. However, in instances where these lifestyle modifications fail to yield desired outcomes, it is reasonable not to withhold safe, effective prescription medications from them. Why not treat overweight patients with these GLP-1 medications to prevent diabetes?

Obstacles for Diabetics Using Ozempic for Weight Loss

The supply chain is catching up, and these medications are available at commercial and compounding pharmacies. Furthermore, Semaglutide is not the only GLP-1 agonist on the market to treat type 2 diabetes, but it is one of the most effective and well-studied options for weight loss. Obesity is poised to strain our healthcare system financially, not the effective treatments designed to combat it.

Taking the Easy Way 

There appears to be a certain mindset prevailing among a subset of individuals—often those already in excellent health. Typically these individuals have dedicated themselves to rigorous gym sessions and disciplined eating habits, as well as those who are inherently thin. This perspective suggests that resorting to Semaglutide equates to taking an easier path. According to this viewpoint, achieving the ideal physique necessitates putting in relentless effort and persevering, just as they do.

However, the truth is, for some individuals, witnessing tangible results is a crucial driving force to ignite their motivation. The notion that embarking on a journey with Semaglutide might offer a shortcut is not necessarily accurate. Rather, it can provide the initial momentum some individuals need to kickstart their commitment and embark on their own journey of hard work and dedication.

“Thin Privilege” and Weight Loss Bias

“Thin privilege” is a subtle yet powerful concept that can perpetuate weight bias in numerous ways, influencing both healthcare professionals and the general public’s attitudes towards people struggling with obesity. People who have always lived in a societal “average” sized body often benefit from a presumption of self-discipline, good health, and personal responsibility, while those with higher body weights may be stigmatized as lazy, lacking willpower, or even morally inferior. Some refer to these ideologies as “fat shaming.”

It is important to recognize that weight is not always within a person’s full control, and factors such as genetics, environment, and socioeconomic status can all contribute to weight gain or obesity. Treating individuals with respect and compassion, regardless of their size, is essential to combating fat phobia and creating a more inclusive and supportive society that promotes improved overall health.

Body Image and Mental Health

Society’s obsession with “thinness” over “health” also significantly influences body image and mental health. Constant exposure to unrealistic beauty standards glorifying thinness can lead to body dissatisfaction and low self-esteem among individuals with higher body weights. This often creates a vicious cycle where negative emotions surrounding body image hinder motivation to pursue healthier lifestyle choices. Many individuals wishing to improve their health and lose weight are embarrassed to begin their journey due to fear of shame. The stigma and judgment surrounding Semaglutide in the media and on social platforms have dissuaded suitable candidates for this treatment from discussing it with their medical providers.

Conclusion

Our pursuit of optimal health transcends arbitrary body standards. It hinges on recognizing the complexity of individual well-being and advocating for evidence-based treatments that empower everyone on their journey. Semaglutide holds transformative potential for weight loss, yet stigma, biases, and societal norms can hinder accessibility for those who need it the most.

Call your nearest Victory Men’s Health location to book a consultation and let us help you reach your goals.

To schedule an appointment:

For more information or to book an appointment at one of our St. Louis area clinics, email info@victorymenshealth.com

—O’Fallon IL 

—Town & Country MO

—Winghaven MO

Sources:

Source 1

Source 2

SHARE: